Paper41009742
Curcumin Alleviates HMGB1-Mediated Inflammation Through the Signaling Pathway of TLR2-NF-κB in Bovine Ovarian Granulosa Cells.
Liu S and 8 others. Int J Mol Sci, 2025. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Curcumin Alleviates HMGB1-Mediated Inflammation Through the Signaling Pathway of TLR2-NF-κB in Bovine Ovarian Granulosa Cells. Papers, record 41009742. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41009742
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Curcumin Alleviates HMGB1-Mediated Inflammation Through the Signaling Pathway of TLR2-NF-κB in Bovine Ovarian Granulosa Cells.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Curcumin | Major topic |
| Toll-Like Receptor 2 | Major topic |
| Granulosa Cells | Major topic |
| HMGB1 Protein | Major topic |
| Signal Transduction | Major topic |
| NF-kappa B | Major topic |
| Inflammation | Major topic |
| Animals | |
| Female | |
| Cattle |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 32172903 | National Natural Science Foundation of China | PubMed | ||
| 2023YFD1800800 | National Key R&D Program of China | PubMed | ||
| CARS-36-04 | China Agriculture Research System | PubMed | ||
| CAAS -ASTIP-2021-LIHPS | Innovation Project of Traditional Chinese Veterinary Medicine and Clinical Science | PubMed |
Source PubMed
References54
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34579002 | Potential Health Benefits of Curcumin on Female Reproductive Disorders: A Review. | Nutrients | 2021 | https://conductscience.org/library/papers/34579002 | PubMed |
| 2 | 33607202 | Supplementation of a combination of herbs improves immunity, uterine cleansing and facilitate early resumption of ovarian cyclicity: A study on post-partum dairy buffaloes. | J Ethnopharmacol | 2021 | https://conductscience.org/library/papers/33607202 | PubMed |
| 3 | 29437881 | Curcumin exerts a protective effect against premature ovarian failure in mice. | J Mol Endocrinol | 2018 | https://conductscience.org/library/papers/29437881 | PubMed |
| 4 | 39171603 | Cytotoxicity and Alkaline Phosphatase Activity of Curcumin, Aloin and MTA on Human Dental Pulp Cells. | Indian J Dent Res | 2024 | https://conductscience.org/library/papers/39171603 | PubMed |
| 5 | 18407514 | Immune-like mechanisms in ovulation. | Trends Endocrinol Metab | 2008 | https://conductscience.org/library/papers/18407514 | PubMed |
| 6 | 34543634 | Curcumin improves angiogenesis in the heart of aged rats: Involvement of TSP1/NF-κB/VEGF-A signaling. | Microvasc Res | 2022 | https://conductscience.org/library/papers/34543634 | PubMed |
| 7 | 27659768 | Development of a novel stirrerliquid/solid microextraction method for the separation and enrichment of trace levels of active compounds in traditional Chinese medicine. | J Sep Sci | 2016 | https://conductscience.org/library/papers/27659768 | PubMed |
| 8 | 37667233 | HMGB1 and Toll-like receptors: potential therapeutic targets in autoimmune diseases. | Mol Med | 2023 | https://conductscience.org/library/papers/37667233 | PubMed |
| 9 | 39334750 | A Review of Recent Curcumin Analogues and Their Antioxidant, Anti-Inflammatory, and Anticancer Activities. | Antioxidants (Basel) | 2024 | https://conductscience.org/library/papers/39334750 | PubMed |
| 10 | 39614566 | Improving curcumin bioavailability: Targeted delivery of curcumin and loading systems in intestinal inflammation. | Food Res Int | 2024 | https://conductscience.org/library/papers/39614566 | PubMed |
| 11 | 37564980 | Molecular mechanisms regulating natural menopause in the female ovary: a study based on transcriptomic data. | Front Endocrinol (Lausanne) | 2023 | https://conductscience.org/library/papers/37564980 | PubMed |
| 12 | 31544976 | Toll-like receptors and high mobility group box 1 in granulosa cells during bovine follicle maturation. | J Cell Physiol | 2020 | https://conductscience.org/library/papers/31544976 | PubMed |
| 13 | 32265930 | Targeting Inflammation Driven by HMGB1. | Front Immunol | 2020 | https://conductscience.org/library/papers/32265930 | PubMed |
| 14 | 28867734 | Curcumin β-D-Glucuronide Plays an Important Role to Keep High Levels of Free-Form Curcumin in the Blood. | Biol Pharm Bull | 2017 | https://conductscience.org/library/papers/28867734 | PubMed |
| 15 | 36948143 | Therapeutic application of natural products: NAD+ metabolism as potential target. | Phytomedicine | 2023 | https://conductscience.org/library/papers/36948143 | PubMed |
| 16 | 39463050 | Bone Healing via Carvacrol and Curcumin Nanoparticle on 3D Printed Scaffolds. | Small | 2024 | https://conductscience.org/library/papers/39463050 | PubMed |
| 17 | 39364745 | Curcumin pretreatment attenuates myocardial ischemia/reperfusion injury by inhibiting ferroptosis, autophagy and apoptosis via HES1. | Int J Mol Med | 2024 | https://conductscience.org/library/papers/39364745 | PubMed |
| 18 | 34837026 | Curcumin derivative ST09 modulates the miR-199a-5p/DDR1 axis and regulates proliferation and migration in ovarian cancer cells. | Sci Rep | 2021 | https://conductscience.org/library/papers/34837026 | PubMed |
| 19 | 37541540 | Curcumin in cancer therapy: Exploring molecular mechanisms and overcoming clinical challenges. | Cancer Lett | 2023 | https://conductscience.org/library/papers/37541540 | PubMed |
| 20 | 29689635 | The pharmacokinetics and tissue distribution of curcumin and its metabolites in mice. | Biomed Chromatogr | 2018 | https://conductscience.org/library/papers/29689635 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42943705 | Medicine-Food Homology Bioactives for Polyendocrine Metabolic Ovarian Syndrome: Multi-Target Mechanisms and Functional Food Translation. | Molecules | 2026 | https://conductscience.org/library/papers/42943705 | PubMed |
| 42589503 | Whole-Transcriptome Profiling of Ovarian Tissues in Gilts with Normal Estrus and Follicular Cyst-Associated Anestrus. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42589503 | PubMed |
| 41669685 | Ginseng and its active compounds in ovarian aging: mechanistic basis and translational prospects. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/41669685 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41009742
GET https://conductscience.org/api/papers/v1/41009742/references?page=2